Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with G
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q4 2022 | GLYCINE | ORAL | SUSPENSION/ DROPS | NA | Deletion | ||
| Q3 2022 | GLYCERIN | ORAL | CONCENTRATE | 750.00 mg/ 1.00 ml | MDE Replacement | ||
| Q4 2022 | GLYCERIN | ORAL | CONCENTRATE | 1800mg | MDE Replacement | ||
| Q3 2022 | GLYCERIN | ORAL | SUSPENSION/ DROPS | 250.00 mg/ 2.50 ml | MDE Replacement | ||
| Q4 2022 | GLYCERIN | ORAL | SUSPENSION/ DROPS | 375mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: October 1, 2022
Database Last Updated: October 19, 2022